Results 31 to 40 of about 14,058,628 (161)

Benefits of Pelvic and Para-Aortic Lymphadenectomy after Neoadjuvant Chemotherapy for Advanced Epithelial Ovarian Cancer with Enlarged Lymph Nodes

open access: yesClinical and Experimental Obstetrics & Gynecology, 2023
Background: This study aimed to evaluate the effectiveness of pelvic and para-aortic lymphadenectomy in patients with advanced epithelial ovarian cancer following neoadjuvant chemotherapy. Methods: This single-center retrospective study analyzed patients
Michiko Kubo-Kaneda   +7 more
doaj   +1 more source

Open Surgery including Lymphadenectomy without Adjuvant Therapy for Uterine-Confined Intermediate- and High-Risk Endometrioid Endometrial Carcinoma

open access: yesCurrent Oncology, 2022
Minimally invasive surgery may not be an appropriate surgical approach in intermediate- and high-risk endometrial carcinoma, even though adjuvant therapy is given.
Isao Otsuka   +4 more
doaj   +1 more source

Pelvic and aortic lymphadenectomy.

open access: yes, 2001
Pelvic and aortic lymphadenectomy for gynecologic malignancies has changed from a random "picking" of some pelvic and aortic lymph nodes to a well-established technique based on adequate knowledge of the patterns of spread of the primary tumor.
BENEDETTI PANICI, PIERLUIGI   +2 more
core   +1 more source

Minilaparoscopic aortic lymphadenectomy

open access: yes, 2015
Study Objective: To show the feasibility of performing aortic lymphadenectomy with 3-mm instruments in gynecologic malignancies. Patient: A 43-year-old, multiparous patient with serous ovarian cancer grading 2, Fédération Internationale de Gynécologie
Chiantera, Vito   +5 more
core   +1 more source

The accuracy of integrated [ 18 F] fluorodeoxyglucose-positron emission tomography/computed tomography in detection of pelvic and para-aortic nodal metastasis in patients with high risk endometrial cancer

open access: yesWorld Journal of Nuclear Medicine, 2014
Lymph nodal (LN) metastasis is the most important prognostic factor in high-risk endometrial cancer. However, the benefit of routine lymphadenectomy in endometrial cancer is controversial.
Nikhil Gholkar   +5 more
doaj   +1 more source

Systematic Lymphadenectomy and Oncological Outcomes of Women With Apparent Early-Stage Clear Cell Carcinoma of the Endometrium: A Multi-Institutional Cohort Study

open access: yesFrontiers in Oncology, 2022
ObjectiveThe survival value of systematic lymphadenectomy for endometrial cancer is ambiguous and controversial. The current study aimed to evaluate the long-term survival role of combined pelvic and para-aortic lymphadenectomy in patients with presumed ...
Yong Tian   +6 more
doaj   +1 more source

Comparative analysis of surgical approaches for para-aortic lymphadenectomy in endometrial cancer patients

open access: yesСибирский онкологический журнал
Background. To date, the role of lymphadenectomy in stage I endometrial cancer has been relegated to the background in favor of sentinel lymph node biopsy.
V. A. Alimov   +7 more
doaj   +1 more source

Endometrial Cancer Lymphadenectomy Trial (ECLAT) (pelvic and para-aortic lymphadenectomy in patients with stage I or II endometrial cancer with high risk of recurrence; AGO-OP.6)

open access: yes, 2021
Background The impact of comprehensive pelvic and para-aortic lymphadenectomy on survival in patients with stage I or II endometrial cancer with a high risk of recurrence is not reliably documented.
de Gregorio, Nikolaus   +9 more
core   +1 more source

Effects of Lymphatic and Venous Invasion Status on Postoperative Prognosis and Metastasis Pattern in Patients With Esophageal Squamous Cell Carcinoma: A Retrospective Cohort Study

open access: yesWorld Journal of Surgery, EarlyView.
Lymphovascular invasion (LVI) is a recognized predictor of poor postoperative outcomes in patients with esophageal squamous cell carcinoma (ESCC). However, only a few studies have evaluated lymphatic invasion (LI) and venous invasion (VI) separately across contemporary perioperative strategies.
Nao Kitasaki   +6 more
wiley   +1 more source

The role of para-aortic lymphadenectomy in stage IIIC endometrial cancer: A single-institute study

open access: yes, 2017
The therapeutic value of para-aortic lymphadenectomy (PAL) in women with endometrial cancer (EC) remains uncertain. We retrospectively analysed 25 patients with stage IIIc EC (17 stage IIIC1; 8 IIIC2) who were treated in our institution. All subjects had
Shigeru Honma   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy